Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2008-03-11
2008-03-11
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S182000, C552S523000
Reexamination Certificate
active
10367623
ABSTRACT:
There is provided use of a compound of Formula XI:wherein R3is a sulphamate group and at least of R1or R2is a thioether group as disclosed by the present specification, capable of inhibiting steroid sulphatase.
REFERENCES:
patent: 3415816 (1968-12-01), Clarke
patent: 3501509 (1970-03-01), Kuo et al.
patent: 4988684 (1991-01-01), Gourvest et al.
patent: 6011024 (2000-01-01), Reed et al.
patent: 0 240 717 (1987-10-01), None
patent: WO 97/30041 (1997-08-01), None
patent: WO 98/24802 (1998-06-01), None
patent: WO 98 24802 (1998-06-01), None
patent: WO 99 33858 (1999-07-01), None
patent: WO 99 64013 (1999-12-01), None
Purohit A et al: “Recent Advances in the Development of Steroid Sulphatase Inhibitors”, Journal of Steroid Biochemistry and Molecular Biology, Elsevier Science Ltd., Oxford, GB, vol. 69, No. 1/6, 1999, pp. 227-238, XP000852540.
Purohitt, Atul et al: “The effect of 2-methoxyoestrone-3-0-sulphamate on the growth of breast cancer cells and induced mammary tumours” retrieved from STN Database accession No. 133:38406, XP002182502, 2000.
Singh, A et al: “Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-0-sulfamate” retrieved from STN Database accession No. 132:318130, XP002182503, 2000.
Purohit A et al: “The Development of A-Ring Modified Analogues of Oestrone-3-0-Sulphamate as Potent Steroid Sulphastase Inhibitors with Reduced Oestrogenicity” Journal of Steroid Biochemistry and Molecular Biology, Elsevier Science Ltd., Oxford, GB, vol. 64, No. 5, 1998, pp. 269-275, XP000852539.
Howarth N M et al: “Estrone Sulfamates: Potent Inhibitors of Estrone Sulfatase with Therapeutic Potential” Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 37, No. 2, Jan. 21, 1994, pp. 219-221, XP000652211.
Cushman M et al: “Snythesis, Antitubulin and Antimitotic Activity, and Cytotoxicity of Analogs of 2-Methoxyestradiol, and Endogenous Mammalian Metabolite of Estradiol that Inhibits Tubulin Polymerization by Binding to the Colchicine Binding Site” Journal of Medicinal Chemistry, American Chemical Society. Washington, US, vol. 38, No. 12, 1995, pp. 2041-2049, XP002055798.
Cushman et al.: “Synthesis of Analogs of 2-Methoxyestradiol with Enhanced Inhieitory Effects of Tubulin Polymerization and Cancer Cell Growth”, J. Med. Chem., vol. 40, 1997, pp. 2323-2334, XP002186112.
Schneider et al.: “Antiestrogen Action of 2-Hydroxyestrone on MCF-7 Human Breast Cancer Cells”, Journal of Biological Chemistry, vol. 259, No. 8, 1984, pp. 4840-4845, XP002186113.
Rajan R et al.: “Estrogen Effects on Nadh Oxidase and Superoxide Dismutase in Prepubertal Female Rats”, Steroids, Elsevier Science Publishers, New York, NY, US, vol. 40, No. 6, Dec. 1, 1982, pp. 651-660, XP002059348.
Kong Q et al.: “Antioxidant Inhibition-Based Strategy for Cancer Therapy” Proceedings of the 90thAnnual Meeting of Research, Philadelphia, PA, Apr. 10-14, 1999, Proceedings of the Annual Meeting of the American Association for Cancer Research, Philadelphia, PA: AACR, US, vol. 40, Mar. 1999, pp. 53, Abstract, XP000882941.
Huang et al.: “Superoxide Dismutase as a Target for the Selective Killing of Cancer Cells”, Nature, vol. 407, Sep. 21, 2000, pp. 390-395, XP002186114.
Kachadourian et al.:“2-Methoxyestradiol does not Inhibit Superoxide Dismutase”, Arch. Biochem. Biophys., vol. 392, No. 2, Aug. 15, 2001, pp. 349-353, XP002186115.
“Woo et al., Heteroatom-Substituted Analogues of the Active-Site Directed Inhibitor Estra-1,3,5(10)-Trien-17-One-3-Sulphamate Inhibit Estrone Sulphatase by a Different Mechanism” J. Steroid BIochem. Molec. Biol. 1996 57(1/2):79-88.
Leese Matthew Paul
Lloyd Potter Barry Victor
Packham Graham Keith
Reed Michael John
Badio Barbara P.
Collison Angela M.
Frommer & Lawrence & Haug LLP
Kowalski Thomas J.
Sterix Ltd.
LandOfFree
Thioether sulphamate steroids as steroid inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thioether sulphamate steroids as steroid inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thioether sulphamate steroids as steroid inhibitors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3916415